Try our Advanced Search for more refined results

J&J Found Liable In 3rd Risperdal Breast-Growth Case

By Matt Fair (December 11, 2015, 4:14 PM EST) -- A Philadelphia jury returned a $500,000 verdict against a Johnson & Johnson unit on Friday after agreeing that the antipsychotic drug Risperdal caused a Wisconsin boy to grow female breasts and that the company had failed to adequately warn doctors about the risks associated with the medication....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!